Sean P. Brusky
Corporate Officer/Principal at PARDES BIOSCIENCES, INC.
Profile
Sean P.
Brusky is currently the Chief Commercial Officer at Pardes Biosciences, Inc. He previously worked as the Head of Healthcare Delivery Innovation at Genentech, Inc. and as a Manager of Business and Corporate Development at Vertex Pharmaceuticals, Inc. He received his undergraduate degree from Brown University and his MBA from Harvard Business School.
Sean P. Brusky active positions
Companies | Position | Start |
---|---|---|
PARDES BIOSCIENCES, INC. | Corporate Officer/Principal | 2021-04-30 |
Former positions of Sean P. Brusky
Companies | Position | End |
---|---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 2004-07-31 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Training of Sean P. Brusky
Brown University | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
Private companies | 2 |
---|---|
Pardes Biosciences, Inc.
Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat and prevent viral diseases. It also focuses on developing novel drugs to solve pandemic-sized problems like the coronavirus disease. The company was founded by Uri A. Lopatin and Lee D. Arnold on February 27, 2020 and is headquartered in Carlsbad, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Sean P. Brusky